2025/9/26
• Posted by Provider Relations
Fidelis Care will host three Provider Office Hours in October 2025. During the webinars, Fidelis Care staff will be available to share information, provide an overview of provider resources, and answer your questions.
Provider Office Hours – October 2025
Topic: Fidelis Care Tools & Resources Overview
When: Thursday, October 9th – 12PM – 1PM EST
Click here to register*
Topic: Fidelis Care and Wellcare - Quality Programs
When: Wednesday, October 15th – 10 AM – 11 AM EST
2025/9/17
• Posted by Provider Relations
The following sections of the Fidelis Care authorization grids have been updated effective October 1, 2025.
The following codes have been updated on the Medicaid, CHP, Essential Plan, Ambetter Metal-Level Plans, and Medicare Authorization Grids and require prior authorization:
C9305 nipocalimab-aahu (Imaavy)
C9306 telisotuzumab vedotin-tllv (Emrelis)
J0614 treosulfan (Grafapex)
J1370 esomeprazole injection
J1809 fosdenopterin
J3402 remestemcel-l-rknd (Ryoncil)
J3403 Revakinagene taroretcel-lwey (Encelto)
J7173 concizumab-mtci (Alhemo)
J7174 fitusiran (Qflitlia)
J9011 datopotamab deruxtecan-dlnk (Datroway)
Q5154 omalizumab-igec (Omlyclo)
Q5155 aflibercept-jbvf (Yesafili)
Q5156 tocilizumab-anoh (Avtozma)
Q5157 denosumab-bmwo (Stoboclo/Osenvelt)
Q5158 denosumab-bnht (Bomyntra/Conexxence)
Q5159 denosumab-dssb (Ospomyv/Xbryk)
For Medicaid, CHP, Essential Plan, Ambetter Metal-Level Plans, and Medicare, the following codes have been added to the list of drugs that require NCH review:
J9011 datopotamab deruxtecan-dlnk (Datroway)
Q5156 tocilizumab-anoh (Avtozma)
Q5157 denosumab-bmwo (Stoboclo/Osenvelt)
Q5158 denosumab-bnht (Bomyntra/Conexxence)
Q5159 denosumab-dssb (Ospomyv/Xbryk)
Visit:
2025/9/10
• Posted by Fidelis Care
旨在支援農村社區創新型預防性保健服務的補助金
紐約長島市（2025年9月10日）飛達利斯保健是一個在全州營運的健康計劃，在紐約州擁有逾240萬名會員，是Centene公司的旗下公司，已啟動2025年鄉村健康補助金計劃的申請流程。該批補助金旨在支援醫療保健服務提供者及社區組織，這些組織致力於構思並打造創新性解決方案，以提升紐約州各農村社區的預防性保健水準。該申請表可在fideliscare.org/rural-grant上找到。申請截止日期為2025年10月3日。
2025/9/9
• Posted by Provider Relations
Fidelis Care would like to inform providers of a significant development impacting COVID-19 vaccine access across New York State.
On Friday, Governor Kathy Hochul signed an executive order declaring a disaster emergency to ensure near-universal access to the latest COVID-19 vaccines. This order, effective through October 5, 2025, enables pharmacists to prescribe and administer the 2025–2026 COVID-19 vaccine formulations to patients ages 3 and older.
While the FDA has only approved the latest vaccine formulations for individuals at high risk of severe illness or those aged 65 and older, the executive order allows broader access in anticipation of the upcoming respiratory virus season.
Key Points
2025/9/5
• Posted by Provider Relations
Fidelis Care is pleased to announce that a new Provider Bulletin is now available. The bulletin features updates on important initiatives and the latest news of interest to our provider community.
Articles in this issue:
· Championing Mental Health: Early Intervention is Key
· Important Reminders About HIV Prevention and Testing
· Supporting Maternal Health for Healthy Pregnancies and Babies
· Encourage Preventive Cancer Screenings
· Help Your Patients of All Ages Stay Active!
· Access and Availability Standards
Please download Fidelis Care Provider Bulletin – Volume 11, Issue 3.
To view our Provider Bulletin Library, please visit: Provider Bulletins.
2025/9/4
• Posted by Provider Relations
As part of an ongoing series, Fidelis Care will highlight some best practices we learn from our partners across the State in the interest of providing the best experience possible for our members.
For this month’s highlight, we’re looking at the Teach-Back Method, a communication technique where providers ask patients to repeat back key information in their own words. This helps confirm understanding, identify confusion, and reinforce learning—especially around diagnoses, medications, and follow-up care.
How It Works
After explaining a concept or instruction, you may want to say: “I want to make sure I explained this clearly. Can you tell me how you’ll manage
Newer Articles
Older Articles